Dr. Rofagha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3300 Telegraph Ave
Oakland, CA 94609Phone+1 510-444-1600Fax+1 510-444-5117
Summary
- Originally from Columbus, Ohio, Dr. Rofagha graduated Summa Cum Laude from The Ohio State University in 2000. She continued her medical training at Ohio State and received a Masters of Public Health at Johns Hopkins University, Bloomberg School of Public Health. She completed residency and vitreoretinal fellowship at University of California, San Francisco. Upon completion of fellowship training, she joined the faculty at UCSF and then joined East Bay Retina Consultants, Inc. in 2013. Dr. Rofagha has special interests in diabetic retinopathy and macular degeneration as well as complex retinal detachment repair. She serves as Principal Investigator for several macular degeneration trials and has authored numerous papers in the peer-reviewed ophthalmic literature. Dr. Rofagha is an Assistant Professor at University of California, San Francisco and holds active memberships in the American Academy of Ophthalmology, the American Society of Retina Specialists, the California Medical Association and the Alameda-Contra Costa Medical Association. She is Board-certified by the American Board of Ophthalmology and is member of the Society of Heed Fellows. She has also received numerous awards including Phi Beta Kappa and Alpha Omega Alpha and was named a Harry S. Truman Scholar.
Education & Training
- University of California (San Francisco)Fellowship, Surgical Retina and Vitreous, 2010 - 2012
- University of California (San Francisco)Residency, Ophthalmology, 2006 - 2009
- OhioHealth/Riverside Methodist HospitalInternship, Transitional Year, 2005 - 2006
- John Hopkins University Bloomberg School of Public HealthMPH, Public Health, 2004 - 2005
- Ohio State University College of MedicineClass of 2005, Magna Cum Laude
- The Ohio State UniversityBA, Political Science, Summa Cum Laude with Honors in the Liberal Arts, 1996 - 2000
Certifications & Licensure
- CA State Medical License 2006 - 2026
- OH State Medical License 2005 - 2006
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- University of California San Francisco Teaching Award UCSF Department of Ophthalmology, 2016
- American Society of Retina Specialists Honor Award American Society of Retina Specialists, 2016
- William F. Hoyt, Outstanding Resident Teach Award on behalf of a Clinical Fellow University of California, San Francisco, Department of Ophthalmology, 2012
- Join now to see all
Clinical Trials
- Intravitreal Aflibercept Injection in Vision Impairment Due to DME Start of enrollment: 2011 May 09
- Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Start of enrollment: 2014 Sep 01
- A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration Start of enrollment: 2014 Sep 18
- Join now to see all
Publications & Presentations
PubMed
- NODULAR EPIRETINAL MÜLLER CELL GLIOSIS IN THE FOVEA.Jesse J Jung, Anne Zeng, Rahul Komati, Anna G Mackin, Dimitra Skondra
Retinal Cases & Brief Reports. 2023-11-01 - 1 citationsSTELLATE MULTIFORM AMELANOTIC CHOROIDOPATHY: Clinical and Multimodal Imaging Features.Prithvi Ramtohul, Marco Pellegrini, Francesco Pichi, Chiara Preziosa, Alessandro Marchese
Retina. 2023-09-01 - 8 citationsComparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to Electronic ETDRS Protocol Visual Acuity Assessment.Carl W Baker, Kristin Josic, Maureen G Maguire, Lee M Jampol, Daniel F Martin
Ophthalmology. 2023-05-01
Abstracts/Posters
- Macular Atrophy Incidence and Rate of Progression over 5 Yrs. Among Ranibizumab-treated Subjects in the ANCHOR, MARINA and HORIZON Trials (SEVEN-UP Study)Mendes T, Bhisitkul RB, Rofagha S, Wayne E, Boyer D, Sadda S, Zhang K (SEVEN-UP), ARVO, Orlando, 1/1/2014
- Retinal and Choroidal Thickness Changes over Time in Patients with Neovascular Age-related Macular Degeneration Treated with Anti-VEGFMendes T, Rofagha S, Bhisitkul RB, ARVO, Seattle, 1/1/2013
- Spontaneous Resolution of a Traumatic Cataract Caused by an Intralenticular Foreign BodyRofagha S, Day S, Winn BJ, Ou J, Bhisitkul R, Chiu CS, American Society of Cataract and Refractive Surgery Annual Meeting, Chicago, IL, 1/1/2008
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
Other Languages
- Farsi, Spanish
Industry Relationships
- Consultant, Carl Zeiss Meditec
External Links
- East Bay Retina Consultants, Inc.http://eastbayretina.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: